Sun Pharma Advanced Research Balance Sheet Health
Financial Health criteria checks 0/6
Sun Pharma Advanced Research has a total shareholder equity of ₹-773.8M and total debt of ₹887.5M, which brings its debt-to-equity ratio to -114.7%. Its total assets and total liabilities are ₹3.2B and ₹4.0B respectively.
Key information
-114.7%
Debt to equity ratio
₹887.50m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹60.70m |
| Equity | -₹773.80m |
| Total liabilities | ₹3.98b |
| Total assets | ₹3.21b |
Recent financial health updates
Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans
Jan 17
Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?
Sep 05Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation
Jun 27Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?
Nov 23Recent updates
Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans
Jan 17Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't
Nov 14Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?
Sep 05Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation
Jun 27Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?
Nov 23If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%
Feb 08
Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?
Dec 14Financial Position Analysis
Short Term Liabilities: SPARC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: SPARC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: SPARC has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: SPARC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SPARC has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SPARC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.1% each year